Authors:
Whitaker, WRJ
Faull, RLM
Dragunow, M
Mee, EW
Emson, PC
Clare, JJ
Citation: Wrj. Whitaker et al., Changes in the mRNAs encoding voltage-gated sodium channel types II and III in human epileptic hippocampus, NEUROSCIENC, 106(2), 2001, pp. 275-285
Authors:
Edgar, PF
Douglas, JE
Cooper, GJS
Dean, B
Kydd, R
Faull, RLM
Citation: Pf. Edgar et al., Comparative proteome analysis of the hippocampus implicates chromosome 6q in schizophrenia, MOL PSYCHI, 5(1), 2000, pp. 85-90
Authors:
Williams, LC
Hegde, MR
Nagappan, R
Faull, RLM
Giles, J
Winship, I
Snow, K
Love, DR
Citation: Lc. Williams et al., Null alleles at the Huntington disease locus: Implications for diagnosticsand CAG repeat instability, GENET TEST, 4(1), 2000, pp. 55-60
Citation: Mc. Munkle et al., The distribution of calbindin, calretinin and parvalbumin immunoreactivityin the human thalamus, J CHEM NEUR, 19(3), 2000, pp. 155-173
Citation: M. Glass et al., The pattern of neurodegeneration in Huntington's disease: A comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations inthe human basal ganglia in Huntington's disease, NEUROSCIENC, 97(3), 2000, pp. 505-519
Authors:
Guan, J
Bennet, L
George, S
Waldvogel, HJ
Faull, RLM
Gluckman, PD
Keunen, H
Gunn, AJ
Citation: J. Guan et al., Selective neuroprotective effects with insulin-like growth factor-1 in phenotypic striatal neurons following ischemic brain injury in fetal sheep, NEUROSCIENC, 95(3), 2000, pp. 831-839
Citation: P. Malherbe et al., Regional and cellular distribution of bleomycin hydrolase mRNA in human brain: comparison between Alzheimer's diseased and control brains, NEUROSCI L, 281(1), 2000, pp. 37-40
Authors:
Alexi, T
Borlongan, CV
Faull, RLM
Williams, CE
Clark, RG
Gluckman, PD
Hughes, PE
Citation: T. Alexi et al., Neuroprotective strategies for basal ganglia degeneration: Parkinson's andHuntington's diseases, PROG NEUROB, 60(5), 2000, pp. 409-470
Authors:
Ohnuma, T
Tessler, S
Arai, H
Faull, RLM
McKenna, PJ
Emson, PC
Citation: T. Ohnuma et al., Gene expression of metabotropic glutamate receptor 5 and excitatory amino acid transporter 2 in the schizophrenic hippocampus, MOL BRAIN R, 85(1-2), 2000, pp. 24-31
Authors:
Selmer, IS
Schindler, M
Humphrey, PPA
Waldvogel, HJ
Faull, RLM
Emson, PC
Citation: Is. Selmer et al., First localisation of somatostatin sst(4) receptor protein in selected human brain areas: an immunohistochemical study, MOL BRAIN R, 82(1-2), 2000, pp. 114-125
Authors:
Mutel, V
Ellis, GJ
Adam, G
Chaboz, S
Nilly, A
Messer, J
Bleuel, Z
Metzler, V
Malherbe, P
Schlaeger, EJ
Roughley, BS
Faull, RLM
Richards, JG
Citation: V. Mutel et al., Characterization of [H-3]quisqualate binding to recombinant rat metabotropic glutamate 1a and 5a receptors and to rat and human brain sections, J NEUROCHEM, 75(6), 2000, pp. 2590-2601
Authors:
Whitaker, WRJ
Clare, JJ
Powell, AJ
Chen, YH
Faull, RLM
Emson, PC
Citation: Wrj. Whitaker et al., Distribution of voltage-gated sodium channel alpha-subunit and beta-subunit mRNAs in human hippocampal formation, cortex, and cerebellum, J COMP NEUR, 422(1), 2000, pp. 123-139
Authors:
Guan, J
Krishnamurthi, R
Waldvogel, HJ
Faull, RLM
Clark, R
Gluckman, P
Citation: J. Guan et al., N-terminal tripeptide of IGF-1 (GPE) prevents the loss of TH positive neurons after 6-OHDA induced nigral lesion in rats, BRAIN RES, 859(2), 2000, pp. 286-292
Authors:
Edgar, PF
Schonberger, SJ
Dean, B
Faull, RLM
Kydd, R
Cooper, GJS
Citation: Pf. Edgar et al., A comparative proteome analysis of hippocampal tissue from schizophrenic and Alzheimer's disease individuals, MOL PSYCHI, 4(2), 1999, pp. 173-178
Authors:
Saura, J
Curatolo, L
Williams, CE
Gatti, S
Benatti, L
Peeters, C
Guan, J
Dragunow, M
Post, C
Faull, RLM
Gluckman, PD
Skinner, SJM
Citation: J. Saura et al., Neuroprotective effects of Gly-Pro-Glu, the N-terminal tripeptide of IGF-1, in the hippocampus in vitro, NEUROREPORT, 10(1), 1999, pp. 161-164
Citation: Kl. Brickell et al., Chemical and anatomical changes in the striatum and substantia nigra following quinolinic acid lesions in the striatum of the rat: a detailed time course of the cellular and GABA(A) receptor changes, J CHEM NEUR, 17(2), 1999, pp. 75-97